▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3058 by analyst upside · 2026-11-12
XRAY
DENTSPLY SIRONA Inc.
Healthcare · Market Cap $2B · P/E 0x
ANALYST PRICE TARGET
+13.0%
implied upside to consensus target
Current Price $9.76
Consensus Target $11.03
Bull Target $17.0
Bear Target $8.0
Analysts Covering 15
ANALYST CONSENSUS - HOLD
Strong Buy
2
Buy
2
Hold
11
Sell
0
52-Week Low $8.14
52-Week High $14.76
YTD Return -13.4%
FUNDAMENTALS
Market Cap $2B
P/E Ratio (TTM) N/A
Forward P/E 7.8x
EPS (TTM) $-0.62
PEG Ratio 0.66
Dividend Yield N/A
Revenue (TTM) $3.6B
Profit Margin -3.4%
52-WEEK RANGE
52-Week Low $8.14
52-Week High $14.76
Current Price $9.76
Bear Target $8.0
Bull Target $17.0
● Now $9.76 ● Target $11.03
TRADING DATA
Avg Volume 4.6M
YTD Return -13.4%
Analyst Count 15
Consensus Hold
Upside to Target +13.0%
Last Updated 2026-11-12

ANALYST SUMMARY

DENTSPLY SIRONA Inc. (XRAY) is currently trading at $9.76 with a Wall Street consensus price target of $11.03, implying potential upside of 13.0% over the next 12 months. 15 analysts currently cover XRAY, with a consensus rating of Hold - 27% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $17.0, while the most cautious has a target of $8.0.

XRAY operates in the Healthcare sector with a market capitalisation of $2B. The stock is down 13.4% year-to-date and is currently trading near the lower end of its 52-week range of $8.14 – $14.76.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

PBH +49.9%
Prestige Consumer Healthcare Inc.
$2B · P/E 13.9x · Buy
MD -4.3%
Pediatrix Medical Group, Inc.
$2B · P/E 17.2x · Hold
ADUS +12.3%
Addus HomeCare Corporation
$2B · P/E 21.1x · Buy
HCSG +5.8%
Healthcare Services Group, Inc.
$2B · P/E 17.0x · Buy
AMN +18.2%
AMN Healthcare Services, Inc.
$1B · P/E 13.8x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for XRAY, with each firm's 90-day track record across all stocks we track. See full firm rankings →

JP Morgan - Reiterated
Neutral → Neutral 2026-11-07 43% win rate (7 calls)
Barrington Research - Reiterated
Outperform → Outperform 2026-10-26 Building track record
Mizuho - Reiterated
Neutral → Neutral 2026-10-22 Building track record
Leerink Partners - Reiterated
Market Perform → Market Perform 2026-10-14 29% win rate (7 calls)
Piper Sandler - Reiterated
Neutral → Neutral 2026-10-09 14% win rate (7 calls)
BMO Capital - Reiterated
Market Perform → Market Perform 2026-09-17 Building track record
Barclays - Reiterated
Underweight → Underweight 2026-08-24 Building track record
Piper Sandler - Reiterated
Neutral → Neutral 2026-07-29 14% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
35
out of 100
Coverage depth
21/30
Consensus clarity
12/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →